State Board of Administration of Florida Retirement System Boosts Stock Position in Nkarta, Inc. (NASDAQ:NKTX)

State Board of Administration of Florida Retirement System boosted its stake in shares of Nkarta, Inc. (NASDAQ:NKTXGet Rating) by 52.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 15,557 shares of the company’s stock after acquiring an additional 5,380 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Nkarta were worth $192,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of NKTX. SR One Capital Management LP purchased a new stake in Nkarta during the 2nd quarter worth about $16,427,000. Deep Track Capital LP increased its holdings in Nkarta by 67.2% during the 1st quarter. Deep Track Capital LP now owns 2,113,795 shares of the company’s stock worth $24,055,000 after purchasing an additional 849,369 shares during the period. Wasatch Advisors Inc. increased its holdings in Nkarta by 33.4% during the 1st quarter. Wasatch Advisors Inc. now owns 842,302 shares of the company’s stock worth $9,585,000 after purchasing an additional 210,700 shares during the period. Silverarc Capital Management LLC purchased a new position in shares of Nkarta in the 2nd quarter valued at about $1,365,000. Finally, Renaissance Technologies LLC increased its holdings in shares of Nkarta by 69.7% in the 1st quarter. Renaissance Technologies LLC now owns 234,000 shares of the company’s stock valued at $2,663,000 after acquiring an additional 96,100 shares during the last quarter.

Nkarta Stock Up 0.6 %

Shares of NASDAQ NKTX opened at $9.11 on Wednesday. The stock has a market cap of $444.70 million, a PE ratio of -3.41 and a beta of 0.13. Nkarta, Inc. has a 52-week low of $7.55 and a 52-week high of $20.35. The business has a 50-day moving average price of $12.45 and a 200 day moving average price of $13.45.

Wall Street Analyst Weigh In

A number of research firms have recently commented on NKTX. Canaccord Genuity Group began coverage on Nkarta in a report on Monday, October 10th. They issued a “buy” rating and a $25.00 price objective on the stock. Oppenheimer dropped their price objective on Nkarta from $50.00 to $36.00 and set an “outperform” rating on the stock in a report on Thursday, November 10th. Canaccord Genuity Group began coverage on Nkarta in a report on Monday, October 10th. They issued a “buy” rating and a $25.00 price objective on the stock. Needham & Company LLC began coverage on Nkarta in a report on Thursday, July 28th. They issued a “buy” rating and a $26.00 price objective on the stock. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Nkarta in a report on Wednesday, September 21st. Ten investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $30.90.

Insiders Place Their Bets

In other Nkarta news, CEO Paul J. Hastings sold 23,376 shares of the stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $13.03, for a total transaction of $304,589.28. Following the completion of the sale, the chief executive officer now directly owns 250,959 shares of the company’s stock, valued at approximately $3,269,995.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Nkarta news, CEO Paul J. Hastings sold 6,126 shares of the stock in a transaction that occurred on Wednesday, September 21st. The stock was sold at an average price of $13.01, for a total transaction of $79,699.26. Following the completion of the sale, the chief executive officer now directly owns 274,335 shares of the company’s stock, valued at approximately $3,569,098.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Paul J. Hastings sold 23,376 shares of the stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $13.03, for a total value of $304,589.28. Following the sale, the chief executive officer now directly owns 250,959 shares of the company’s stock, valued at $3,269,995.77. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,344 shares of company stock valued at $396,093. 5.60% of the stock is owned by company insiders.

Nkarta Company Profile

(Get Rating)

Nkarta, Inc, a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells.

Read More

Want to see what other hedge funds are holding NKTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nkarta, Inc. (NASDAQ:NKTXGet Rating).

Institutional Ownership by Quarter for Nkarta (NASDAQ:NKTX)

Receive News & Ratings for Nkarta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nkarta and related companies with MarketBeat.com's FREE daily email newsletter.